LICENSE AGREEMENTLicense Agreement • December 6th, 2018 • Immunomedics Inc • In vitro & in vivo diagnostic substances • California
Contract Type FiledDecember 6th, 2018 Company Industry JurisdictionThis License Agreement (the “Agreement”) is effective as of April 4, 2018 (the “Effective Date”), by and between THE SCRIPPS RESEARCH INSTITUTE, a California nonprofit public benefit corporation (“TSRI”), and IMMUNOMEDICS, INC., a Delaware corporation (“Licensee”), each located at the respective address set forth in Section 13.15 below, with respect to the facts set forth below.
LICENSE AGREEMENTLicense Agreement • August 23rd, 2018 • Immunomedics Inc • In vitro & in vivo diagnostic substances • California
Contract Type FiledAugust 23rd, 2018 Company Industry JurisdictionThis License Agreement (the “Agreement”) is effective as of April 4, 2018 (the “Effective Date”), by and between THE SCRIPPS RESEARCH INSTITUTE, a California nonprofit public benefit corporation (“TSRI”), and IMMUNOMEDICS, INC., a Delaware corporation (“Licensee”), each located at the respective address set forth in Section 13.15 below, with respect to the facts set forth below.